By Maria Júlia Baumert ( August 19, 2026, 14:55 GMT | Insight) -- The Brazilian competition authority has opened a new round of market testing in its review of Novamed’s proposed acquisition of Medley Farmacêutica from Sanofi, asking competitors about six pharmaceutical categories where the companies’ portfolios overlap.The Brazilian competition authority has opened a new round of market testing in its review of Novamed’s proposed acquisition of Medley Farmacêutica from Sanofi, asking competitors about six pharmaceutical categories where the companies’ portfolios overlap: topical dermatological antifungals, topical antivirals, topical anti-acne products, gonadotropins and other ovulation stimulants, selective serotonin agonists for migraine, and tranquilizers....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.